Zinc gluconate lozenges for treating the common cold in children: A randomized controlled trial

JAMA

Volumn 279, Issue 24, 1998, Pages 1962-1967

  Macknin, Michael L ^a   Piedmonte, Marion ^a   Calendine, Cory ^a   Janosky, Janine ^b   Wald, Ellen ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCONATE ZINC; PLACEBO;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LOZENGE; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TASTE DISORDER; THROAT DISEASE; TONGUE DISEASE; TREATMENT OUTCOME;

EID: 0032562986     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.24.1962     Document Type: Article

References (33)

1. Dingle JH, Badger GF, Jordan WS Jr. Illness in the Home: Study of 25 000 Illnesses in a Group of Cleveland Families. Cleveland, Ohio: Press of Western Reserve University; 1964.
2. Gwaltney JM Jr, Hendley JO, Simon G, Jordan WS Jr. Rhinovirus infections in an industrial population, I: the occurrence of illness. N Engl J Med. 1966;275:1261-1268.
3. Couch RB. The common cold: control? J Infect Dis. 1984;150:167-173.
4. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common cold by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. 1984;25:20-24.
5. Al-Nakib W, Higgins PG, Barrow I, Batstone G, Tyrrell DAJ. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother. 1987;20:893-901.
6. Godfrey JC, Sloan BC, Smith DS, Turco JH, Mercer N, Godfrey NJ. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res. 1992; 20:234-246.
7. Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold: a randomized, double-blind, placebo-controlled study. Ann Intern Med. 1996;125:81-88.
8. Farr BM, Conner EM, Betts RF, Oleske J, Minnefor A, Gwaltney JM Jr. Two randomized controlled trials of zinc gluconate lozenges therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother. 1987;31:1183-1187.
9. Douglas RM, Miles HB, Moore BW, Ryan P, Pinnock CB. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infection in Australian adults. Antimicrob Agents Chemother. 1987;31:1263-1265.
10. Smith DS, Helzner EC, Nuttall CE Jr, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother. 1989;33:646-648.
11. Weismann K, Jakobsen JP, Weismann JE, et al. Zinc gluconate lozenges for common cold. Dan Med Bull. 1990;37:279-281.
12. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. J Chronic Dis. 1967;20:637-648.
13. Simon G, Wagner E, Von Korff M. Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs. J Clin Epidemiol. 1995;48:363-373.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-486.
15. Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics. 1982; 38:29-41.
16. Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34:187-220.
17. Efron B. The efficiency of Cox's likelihood function for censored data. J Am Stat Assoc. 1977;72: 557-565.
18. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
19. Jackson JL, Peterson C, Lesho E. A meta-analysis of zinc salts lozenges and the common cold. Arch Intern Med. 1997;157:2373-2376.
20. Korant BD, Butterworth BE. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. J Virol. 1976;18:298-306.
21. Geist FC, Bateman JA, Hayden FG. In vitro activity of zinc salts against human rhinoviruses. Antimicrob Agents Chemother. 1987;31:622-624.
22. Gordon YJ, Asher Y, Becker Y. Irreversible inhibition of herpes simplex virus replication in BSC-1 cells by zinc ions. Antimicrob Agents Chemother. 1974;8:377-380.
23. Firpo EJ, Palma EL. Inhibition of foot and mouth disease virus and procapsid synthesis by zinc ions: brief report. Arch Virol. 1979;61:175-181.
24. Ratka M, Lackmann M, Ueckermann C, Karlins U, Koch G. Poliovirus-associated protein kinase: destablization of the virus capsid and stimulation of the phosphorylation reaction by Xn2+. J Virol. 1989;63:3954-3960.
25. Moffat AS. Going back to the future with small synthetic compounds. Science. 1993;260:910-912.
26. Novick SG, Godfrey JC, Godfrey NJ, Wider HR. How does zinc modify the common cold? clinical observations and implications regarding mechanism of action. Med Hypotheses. 1996;46:295-302.
27. Pasternak CA. A novel form of host defense: membrane protection by Ca2+ and Zn2+. Biosci Rep. 1987;7:81-91.
28. Bashford CL, Alder GM, Menestrina G, Micklem KJ, Murphy JJ, Pasternak CA. Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents: a common mechanism blocked by divalent cations. J Biol Chem. 1986;261:9300-9308.
29. Harisch G, Kretschmer M. Some aspects of a non-linear effect of zinc ions on the histamine release from rat peritoneal mast cells. Res Commun Chem Pathol Pharmacol. 1987;55:39-48.
30. Marone G, Findlay SR, Lichtenstein LM. Modulations of basophil histamine release by zinc. J Allergy Clin Immunol. 1979;65:171.
31. Salas M, Kirchner H. Induction of interferon-gamma in human leukocyte cultures stimulated by Zn2+. Clin Immunol Immunopathol. 1987;45: 139-142.
32. Kelly RW, Abel MH. Copper and zinc inhibit the metabolism of prostaglandin by the human uterus. Biol Reprod. 1983;28:883-889.
33. Prasad AS. Zinc: the biology and therapeutics of an ion. Ann Intern Med. 1996;125:142-144.